Mark Emalfarb

Founder & CEO of @DyadicInc $DYAI pioneering sustainable biotech solutions to improve access to non animal recombinant proteins for food, nutrition and health.

[Mark Emalfarb @Emalfarb]

Sustainability and Global Impact:

The video emphasizes @DyadicInc commitment to #sustainability and the potential for these technological improvements to positively impact global #health, #nutrition, and #food sectors. $DYAI

#proteins #StocksToWatch

https://t.co/TEgFZql1il

[Mark Emalfarb @Emalfarb]

@DrTedros The world doesn’t just need stronger health systems. It needs stronger biomanufacturing infrastructure & innovation so that life-saving countermeasures reach everyone, not just those who can afford them.
$dyai #vaccines #antibodies #ebola

[Mark Emalfarb @Emalfarb]

@DrTedros COVID-19 exposed this vulnerability. The next threat could be far more lethal than COVID. If an Ebola or Hantavirus-like pathogen ever achieves efficient human-to-human transmission, mfg speed, scalability, & affordability may determine how many lives can actually be saved
$DYAI

[Mark Emalfarb @Emalfarb]

@business The 2026 #Bundibugyo outbreak is another warning that preparedness cannot begin after an outbreak starts. Manufacturing speed, scalability, affordability and distributed global capacity must become central pillars of biodefense strategy before the next Disease X emerges. $DYAI

[Mark Emalfarb @Emalfarb]

@DrTedros @WHO The 2026 #Bundibugyo outbreak is another warning that preparedness cannot begin after an outbreak starts. Manufacturing speed, scalability, affordability and distributed global capacity must become central pillars of biodefense strategy before the next Disease X emerges. $DYAI

[Mark Emalfarb @Emalfarb]

@BBCWorld The 2026 #Bundibugyo outbreak is another warning that preparedness cannot begin after an outbreak starts. Manufacturing speed, scalability, affordability and distributed global capacity must become central pillars of biodefense strategy before the next Disease X emerges. $DYAI

[Mark Emalfarb @Emalfarb]

@BBCNews The 2026 #Bundibugyo outbreak is another warning that preparedness cannot begin after an outbreak starts. Manufacturing speed, scalability, affordability and distributed global capacity must become central pillars of biodefense strategy before the next Disease X emerges. $DYAI

[Mark Emalfarb @Emalfarb]

@Telegraph The 2026 #Bundibugyo outbreak is another warning that preparedness cannot begin after an outbreak starts. Manufacturing speed, scalability, affordability and distributed global capacity must become central pillars of biodefense strategy before the next Disease X emerges. $DYAI

[Mark Emalfarb @Emalfarb]

@AfricaCDC The 2026 #Bundibugyo outbreak is another warning that preparedness cannot begin after an outbreak starts. Manufacturing speed, scalability, affordability and distributed global capacity must become central pillars of biodefense strategy before the next Disease X emerges.

[Mark Emalfarb @Emalfarb]

@Reuters The 2026 #Bundibugyo outbreak is another warning that preparedness cannot begin after an outbreak starts. Manufacturing speed, scalability, affordability and distributed global capacity must become central pillars of biodefense strategy before the next Disease X emerges.

[Mark Emalfarb @Emalfarb]

@AfricaMediaHub @StateDept The 2026 #Bundibugyo outbreak is another warning that preparedness cannot begin after an outbreak starts. Manufacturing speed, scalability, affordability and distributed global capacity must become central pillars of biodefense strategy before the next Disease X emerges.

[Mark Emalfarb @Emalfarb]

@Reuters @JHF_Voss The world does not just have a discovery problem.

It has a biologics manufacturing problem.
Faster, higher-yield, lower-cost manufacturing technologies must become part of global health preparedness discussions before the next crisis arrives. $DYAI #ebola #antibodies #vaccines

[Mark Emalfarb @Emalfarb]

@antonioguterres The world does not just have a discovery problem.

It has a biologics manufacturing problem.
Faster, higher-yield, lower-cost manufacturing technologies must become part of global health preparedness discussions before the next crisis arrives. $DYAI #ebola #antibodies #vaccines

[Mark Emalfarb @Emalfarb]

@StandardKenya The world does not just have a discovery problem.

It has a biologics manufacturing problem.
Faster, higher-yield, lower-cost manufacturing technologies must become part of global health preparedness discussions before the next crisis arrives. $DYAI #ebola #antibodies #vaccines

[Mark Emalfarb @Emalfarb]

@DrTedros The world does not just have a discovery problem.

It has a biologics manufacturing problem.
Faster, higher-yield, lower-cost manufacturing technologies must become part of global health preparedness discussions before the next crisis arrives. $DYAI #ebola #antibodies #vaccines

[Mark Emalfarb @Emalfarb]

@Dr_JeanKaseya @AfricaCDC @_AfricanUnion @MinSanteRDC @PrimatureRDC @WHOUganda @MinofHealthUG @Com_mediasRDC @MoHRSS2011 @WHOAFRO The world does not just have a discovery problem.

It has a biologics manufacturing problem.
Faster, higher-yield, lower-cost manufacturing technologies must become part of global health preparedness discussions before the next crisis arrives. $DYAI #ebola #antibodies #vaccines

[Mark Emalfarb @Emalfarb]

@allenanalysis The world does not just have a discovery problem.

It has a biologics manufacturing problem.
Faster, higher-yield, lower-cost manufacturing technologies must become part of global health preparedness discussions before the next crisis arrives. $DYAI #ebola #antibodies #vaccines

[Mark Emalfarb @Emalfarb]

@Reuters The world does not just have a discovery problem.

It has a biologics manufacturing problem.
Faster, higher-yield, lower-cost manufacturing technologies must become part of global health preparedness discussions before the next crisis arrives. $DYAI #ebola #antibodies #vaccines

[Mark Emalfarb @Emalfarb]

@mvankerkhove @WHO The world does not just have a discovery problem.

It has a biologics manufacturing problem.
Faster, higher-yield, lower-cost manufacturing technologies must become part of global health preparedness discussions before the next crisis arrives. $DYAI #ebola #antibodies #vaccines